ARKEMA (AKE.PA)

FR0010313833 - Common Stock

72.15  +2 (+2.85%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
9.519B
20.74%
11.55B
21.34%
9.514B
-17.63%
9.717B
2.13%
10.204B
5.01%
10.632B
4.19%
11.329B
6.56%
11.72B
3.45%
12.084B
3.11%
12.471B
3.20%
12.49B
0.15%
EBITDA
YoY % growth
1.933B
47.56%
2.149B
11.17%
1.462B
-31.97%
1.563B
6.91%
1.678B
7.36%
1.8B
7.27%
1.982B
10.11%
2.087B
5.30%
2.233B
7.00%
2.367B
6.00%
N/A
EBIT
YoY % growth
1.116B
98.58%
1.442B
29.21%
744M
-48.40%
905.12M
21.66%
1.016B
12.25%
1.121B
10.33%
1.317B
17.48%
1.404B
6.61%
1.514B
7.83%
1.626B
7.40%
N/A
Operating Margin
11.72%12.48%7.82%9.31%9.96%10.54%11.63%11.98%12.53%13.04%N/A
EPS
YoY % growth
11.84
132.16%
15.63
32.01%
8.74
-44.08%
8.89
1.70%
10.12
13.87%
11.16
10.24%
12.62
13.13%
13.61
7.86%
14.60
7.23%
15.72
7.66%
N/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
1.63
14.47%
2.13
15.60%
2.97
4.17%
2.76
22.86%
1.82
11.84%
Revenue
Q2Q % growth
2.284B
2.56%
2.55B
8.93%
2.766B
9.07%
2.676B
11.78%
N/A
EBITDA
Q2Q % growth
329.45M
-61.65%
392.27M
19.96%
504.36M
-22.41%
471.43M
-40.33%
N/A
EBIT
Q2Q % growth
172.96M
22.67%
232.15M
68.22%
341.79M
27.53%
304.96M
46.62%
N/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.25
-5.46%
2.29-0.04-1.73%
Q2 2024
Q2Q % growth
2.85
2.89%
2.630.228.44%
Q1 2024
Q2Q % growth
1.84
-15.21%
1.690.158.93%
Q4 2023
Q2Q % growth
1.42
22.41%
1.88-0.46-24.41%
Q3 2023
Q2Q % growth
2.38
-32.39%
2.290.093.87%
Q2 2023
Q2Q % growth
2.77
-53.76%
2.380.3916.15%
Q1 2023
Q2Q % growth
2.17
-56.25%
1.790.3821.00%
Q4 2022
Q2Q % growth
1.16
-59.30%
1.120.043.15%
Q3 2022
Q2Q % growth
3.52
3.23%
3.160.3611.38%
Q2 2022
Q2Q % growth
5.99
71.14%
4.431.5635.08%
Q1 2022
Q2Q % growth
4.96
138.46%
3.281.6851.10%
Q4 2021
Q2Q % growth
2.85
137.50%
1.960.8945.48%
Q3 2021
Q2Q % growth
3.41
140.14%
2.750.6624.13%
Q2 2021
Q2Q % growth
3.50
199.15%
2.471.0341.46%
Q1 2021
Q2Q % growth
2.08
58.78%
1.710.3721.98%
Q4 2020
Q2Q % growth
1.20
-9.77%
0.990.2120.67%
Q3 2020
Q2Q % growth
1.42
-34.56%
1.44-0.02-1.29%
Q2 2020
Q2Q % growth
1.17
-53.39%
0.990.1817.96%
Q1 2020
Q2Q % growth
1.31
-39.35%
1.37-0.06-4.23%
Q4 2019
Q2Q % growth
1.33 1.51-0.18-11.96%
Q3 2019
Q2Q % growth
2.17 2.20-0.03-1.22%
Q2 2019
Q2Q % growth
2.51 2.420.093.55%
Q1 2019
Q2Q % growth
2.16 2.18-0.02-1.11%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.394B
2.92%
2.457B-63M-2.56%
Q2 2024
Q2Q % growth
2.536B
3.85%
2.456B80M3.26%
Q1 2024
Q2Q % growth
2.341B
-7.25%
2.395B-54M-2.25%
Q4 2023
Q2Q % growth
2.227B
-11.17%
2.226B1M0.04%
Q3 2023
Q2Q % growth
2.326B
-21.74%
2.345B-19M-0.81%
Q2 2023
Q2Q % growth
2.442B
-23.30%
2.58B-138M-5.35%
Q1 2023
Q2Q % growth
2.524B
-12.57%
2.588B-64M-2.47%
Q4 2022
Q2Q % growth
2.507B
0.28%
2.502B5M0.20%
Q3 2022
Q2Q % growth
2.972B
23.94%
2.949B23M0.78%
Q2 2022
Q2Q % growth
3.184B
32.94%
2.976B208M6.99%
Q1 2022
Q2Q % growth
2.887B
29.69%
2.786B101M3.63%
Q4 2021
Q2Q % growth
2.5B
25.94%
2.31B190M8.23%
Q3 2021
Q2Q % growth
2.398B
25.62%
2.297B101M4.40%
Q2 2021
Q2Q % growth
2.395B
25.92%
2.298B97M4.22%
Q1 2021
Q2Q % growth
2.226B
6.61%
2.169B57M2.63%
Q4 2020
Q2Q % growth
1.985B
-3.31%
1.874B111M5.92%
Q3 2020
Q2Q % growth
1.909B
-13.85%
1.918B-9M-0.47%
Q2 2020
Q2Q % growth
1.902B
-15.62%
1.857B45M2.42%
Q1 2020
Q2Q % growth
2.088B
-5.73%
2.103B-15M-0.71%
Q4 2019
Q2Q % growth
2.053B 2.224B-171M-7.69%
Q3 2019
Q2Q % growth
2.216B 2.223B-7M-0.31%
Q2 2019
Q2Q % growth
2.254B 2.29B-36M-1.57%
Q1 2019
Q2Q % growth
2.215B 2.24B-25M-1.12%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -30.13% 0% -2.93%
Revenue0% -8.64% 0% -0.3%